Omzet 2024 * | - | Omzet 2025 * | - | Marktkapitalisatie | 4,23 mln. 3,9 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -12 mln. -11,07 mln. | Nettowinst (verlies) 2025 * | -14 mln. -12,91 mln. | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | - |
K/w-verhouding 2024 * |
-0,39
x | K/w-verhouding 2025 * |
-0,38
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 87,74% |
Recentste transcriptie over Processa Pharmaceuticals Inc
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Wendy Guy
FOU | Founder | 59 | 29-03-11 |
Sian Bigora
FOU | Founder | 63 | 29-03-11 |
David Young
FOU | Founder | 71 | 29-03-11 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
George Ng
CEO | Chief Executive Officer | 49 | 08-08-23 |
James Neal
BRD | Director/Board Member | 68 | 16-07-22 |
Justin Yorke
CHM | Chairman | 58 | 02-10-17 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+40,73% | 739 mld. | |
+32,83% | 598 mld. | |
-6,30% | 353 mld. | |
+15,15% | 318 mld. | |
+4,05% | 285 mld. | |
+15,00% | 240 mld. | |
+9,78% | 210 mld. | |
-5,52% | 206 mld. | |
+6,17% | 164 mld. |